arrow
Y

Yee‐Kit Tse

the chinese university of hong kong
H-index:36
Citation Count:4,051
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

Long-Term Incidence of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance

乙型肝炎表面抗原血清清除后肝细胞癌的长期发病率

2026-07-130
PRE
Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer

乙型肝炎病毒再激活在肝癌患者中接受免疫检查点抑制剂或酪氨酸激酶抑制剂治疗时的比较风险

2025-09-050
OAAI
Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B
2024-04-0113
PRE
Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients
2023-10-018
PRE
Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection
2023-07-285
PRE
Baveno VII criteria identify varices needing treatment in patients with hepatocellular carcinoma of different Barcelona Clinic Liver Cancer stages
2023-05-228
PRE
Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis

非酒精性脂肪性肝病患者2型糖尿病持续时间和肝脏相关事件的里程碑分析

2023-05-015
PRE
Clinical Outcomes Following Treatment for COVID-19 With Nirmatrelvir/Ritonavir and Molnupiravir Among Patients Living in Nursing Homes
2023-04-278
OAAI
Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss
2023-03-0120
PRE
Trends in risk factor control and treatment among patients with non-alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory-wide study
2023-02-234
OAAI
Drug-drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study
2022-09-089
PRE
Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma
2022-07-2125
PRE
Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease
2022-07-1532
PRE
Tenofovir alafenamide is associated with improved alanine aminotransferase and renal safety compared to tenofovir disoproxil fumarate
2022-05-254
PRE
Risk of liver-related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease
2022-04-0731
PRE
Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis
2022-03-0131
OAAI
Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver disease
2022-01-2452
PRE
Secular trend of treatment uptake in patients with chronic hepatitis B: A territory-wide study of 135 395 patients from 2000 to 2017
2021-08-279
OAAI
Serum fibrosis index-based risk score predicts hepato-cellular carcinoma in untreated patients with chronic hepatitis B
2021-07-0115
OAAI
Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID-19
2021-06-2143
OA